The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Generation Bio Co’s current trading price is -86.77% away from its 52-week high, while its distance from the 52-week low is 2.02%. The stock’s price range for this period has been between $0.60 and $4.65 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 0.59 million for the day, a number notably higher than the average daily volume of 0.48 million over the last three months.
In terms of market performance, Generation Bio Co had a fairly uneven. The highest value for the stock in the past year was $4.65 on 04/01/24, and the lowest value was recorded at $0.60 on 02/12/25.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Generation Bio Co (GBIO) has experienced a quarterly decline of -60.06% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 41.07M and boasts a workforce of 174 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.4946, with a change in price of -1.9250. Similarly, Generation Bio Co recorded 345,877 in trading volume during the last 100 days, posting a change of -75.79%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for GBIO stands at 0.90. Similarly, the long-term debt-to-equity ratio is also 0.79.
GBIO Stock Stochastic Average
Generation Bio Co’s raw stochastic average for the past 50 days is presently 1.57%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 3.10%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 12.33% and 16.09%, respectively.
GBIO Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -41.98% this year. Over the last six months, there has been a stronger performance of -76.97%. The price of GBIO leaped by -37.87% during the last 30 days period. For the last 5-days stocks have slided -0.65%.
